Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MH002 in Mild-to-Moderate Ulcerative Colitis
NCT07296315Phase 2Recruiting
- Sponsor
- MRM Health
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 7
01
Overview
A Phase 2 trial of MH002 in ulcerative colitis (UC), sponsored by MRM Health. Started Apr 2026; status: recruiting.
02
Drugs
MH002
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07296315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296315.